Most probably, the amount of IL-2/IL-2 mAb used in murine models is not physiologically relevant and further work is required to titrate the dose of cytokine required to protect against atherosclerosis without inducing undesirable side effects. The gene discussed is IL2; the disease is atherosclerosis.